390 related articles for article (PubMed ID: 17206224)
1. [Survey on vaccination strategies used in different Italian Regions, for the 7-valent conjugate pneumococcal, meningococcal C and varicella vaccines].
D'Ancona F; Alfonsi V; Ciofi degli Atti ML
Ig Sanita Pubbl; 2006; 62(5):483-92. PubMed ID: 17206224
[TBL] [Abstract][Full Text] [Related]
2. Current immunization policies for pneumococcal, meningococcal C, varicella and rotavirus vaccinations in Italy.
Alfonsi V; D'Ancona F; Giambi C; Nacca G; Rota MC;
Health Policy; 2011 Dec; 103(2-3):176-83. PubMed ID: 22030308
[TBL] [Abstract][Full Text] [Related]
3. Prevention of invasive diseases: strategies to increase vaccination coverage in children and adolescents.
Zoppi G; Trucchi C
J Prev Med Hyg; 2012 Jun; 53(2):125-9. PubMed ID: 23240175
[TBL] [Abstract][Full Text] [Related]
4. [Acceptance of the new conjugate vaccines. Meningococcal and pneumococcal vaccines, in the cohort born in 1999, in the North Region of Portugal].
De Queirós L; Castro L; Ferreira MC; Gonçalves G
Acta Med Port; 2004; 17(1):49-53. PubMed ID: 15636727
[TBL] [Abstract][Full Text] [Related]
5. [Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk].
de Greeff SC; Sanders EA; de Melker HE; van der Ende A; Vermeer PE; Schouls LM
Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1454-7. PubMed ID: 17633974
[TBL] [Abstract][Full Text] [Related]
6. Invasive bacterial diseases: national surveillance in Italy and vaccination coverage in the Local Health Agency 4 "Chiavarese", Liguria region (Italy).
Trucchi C; Zoppi G
J Prev Med Hyg; 2012 Jun; 53(2):120-4. PubMed ID: 23240174
[TBL] [Abstract][Full Text] [Related]
7. [Serious invasive pneumococcal disease in young children: the importance of vaccination].
Haveman LM; Geelen SP; Sanders EA; Wolfs TF
Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1917-20. PubMed ID: 12404904
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life.
Adamkiewicz TV; Silk BJ; Howgate J; Baughman W; Strayhorn G; Sullivan K; Farley MM
Pediatrics; 2008 Mar; 121(3):562-9. PubMed ID: 18310206
[TBL] [Abstract][Full Text] [Related]
11. [Centralized immunization schedules and regional equity of access: an audit among Apulian healthcare workers].
Tafuri S; Martinelli D; Caputi G; Fortunato F; Germinario C; Prato R
Ann Ig; 2009; 21(2):127-34. PubMed ID: 19653444
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.
Vestrheim DF; Løvoll O; Aaberge IS; Caugant DA; Høiby EA; Bakke H; Bergsaker MR
Vaccine; 2008 Jun; 26(26):3277-81. PubMed ID: 18456376
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects.
Lloyd A; Patel N; Scott DA; Runge C; Claes C; Rose M
Eur J Health Econ; 2008 Feb; 9(1):7-15. PubMed ID: 17333089
[TBL] [Abstract][Full Text] [Related]
14. Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.
Chevallier B; Vesikari T; Brzostek J; Knuf M; Bermal N; Aristegui J; Borys D; Cleerbout J; Lommel P; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S109-18. PubMed ID: 19325447
[TBL] [Abstract][Full Text] [Related]
15. Prevnar (heptavalent pneumococcal conjugate vaccine): disease prevention in infants and children.
Shields B
J Pediatr Health Care; 2001; 15(4):203-8; quiz 209-10. PubMed ID: 11462129
[No Abstract] [Full Text] [Related]
16. Effectiveness of the 7-valent pneumococcal conjugate vaccine: a population-based case-control study.
Barricarte A; Castilla J; Gil-Setas A; Torroba L; Navarro-Alonso JA; Irisarri F; Arriazu M
Clin Infect Dis; 2007 Jun; 44(11):1436-41. PubMed ID: 17479939
[TBL] [Abstract][Full Text] [Related]
17. HHS-CDC news: Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--US, 1998-2003.
Ann Pharmacother; 2005 Nov; 39(11):1967-8. PubMed ID: 16219891
[No Abstract] [Full Text] [Related]
18. Update on the recommendations for the routine use of pneumococcal conjugate vaccine for infants. An Advisory Committee Statement (ACS).
National Advisory Committee on Immunization (NACI)
Can Commun Dis Rep; 2006 May; 32(ACS-4):1-6. PubMed ID: 16718922
[No Abstract] [Full Text] [Related]
19. Vaccine co-administration in paediatric age: the experience of the Local Health Unit of Cuneo-1 (Ambito di Cuneo), Italy.
Pellegrino A; Busellu G; Cucchi A; Cavallaro A; Gabutti G;
Acta Biomed; 2010 Dec; 81(3):204-9. PubMed ID: 22530458
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal and Meningococcal Vaccination among Michigan Children with Sickle Cell Disease.
Wagner AL; Shrivastwa N; Potter RC; Lyon-Callo SK; Boulton ML
J Pediatr; 2018 May; 196():223-229. PubMed ID: 29555094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
